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ABSTRACT 
 
Stroke is a significant contributor to disease worldwide and is the second highest cause of 
death in both men and women. Importantly, stroke is not only a common cause or mortality but 
also morbidity. This increased risk of suffering a stroke could lead to an increased number of 
individuals with functional limitations. The main objective in stroke rehabilitation is seen as 
aiding the patient to achieve their highest physical and psychological performance, with the 
ultimate goal of a stroke survivor being one of functional independence allowing them to return 
to their home and reintegrate into their community. The aim of this study is to describe the 
differences in functional abilities between patients with stroke who are HIV positive and those 
who are HIV negative admitted to Witrand rehabilitation unit in the North-West province of 
South Africa. 
 
This is a retrospective longitudinal study utilizing the review of subject records. All subject files 
dating back to 21 April 2005 to December 2010 were analysed. Functional ability of patients 
with stroke was scored using the Beta assessment tool.The Beta assessment tool is one of 
three platform level tools designed by the South African Database for Functional Medicine 
(SADFM).It is an evidence – based scoring system which can convert a patient’s functional 
abilities and behaviour into quantifiable data. Scores on admission and discharge were 
recorded to determine the presence of change in functional ability after having received 
rehabilitation. Demographic information and clinical characteristics of subjects were captured 
using a self-designed questionnaire. Data were analysed using both a two sample t-test and 
descriptive statistical tests. 
 
Over the period, 2005 – 2010, 173 stroke survivors were admitted to the Witrand rehabilitation 
unit.Data from 32 patient files was excluded for not meeting the inclusion criteria; leaving data 
from 141 files to form our study group (n).  The study group included 53.2% male and 46.8% 
female stroke survivors, with the mean age for stroke at 54.4 years and52.4 years for males 
and females respectively.  Ischaemic strokes were more prevalent than haemorrhagic strokes 
(74.5% and 25.5% respectively) with hypertension asthe most common (31.9%) stroke risk 
factor. The mean age of stroke onset for a HIV positive individual was 39.6 years and 54.9 
years for an individual without HIV.This study found that HIV positive individuals required on 
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average 7.5 days less to rehabilitate than an individual with HIV. This discrepancy could be a 
result of the notably younger HIV positive group. After receiving rehabilitation from a 
multidisciplinary team, the HIV positive group improved with an average of 40 points and the 
individuals without HIV by 38 points. When performing the various statistical tests there were in 
fact no significant differences between the two different clinical groups.  
 
Despite the statistically insignificant findings when comparing the HIV positive and HIV negative 
group, when taking a closer look at the study groups demographics and clinical characteristics 
this study yielded interesting results. It could be argued that a majority of the HIV positive group 
were generally younger than the HIV negative group and perhaps the advantage of age on 
recovery could result in this group in gaining, on average, a similar number of points on the beta 
scale with those individual without HIV.Prior to their commencement of rehabilitation it should 
be taken into account that neurological recovery requires a degree of brain reorganization and 
that with age comes a certain degree of neuronal loss. Neuroplasticity is the ability of the central 
nervous system to respond to internal and external stimuli by reorganizing its structure, function 
and connections.  Normal ageing is associated with a decline in and reduced plasticity. These 
negative changes can be experienced as reductions in processing speed, working memory and 
peripheral nervous system functions; all of which can be associated with poorer rehabilitation 
outcomes. Neural plasticity is crucial for functional recovery and this occurs more effectively 
and efficiently in younger individuals.However, in general the age for stroke onset was younger 
than that of developed countries thus stroke should no longer be considered an ‘old-age’ 
disease in developing countries.  
 
 
Keywords: Stroke; Human Immunodeficiency Virus (HIV); Functional abilities 
 
 
 
 
 
 
 
vi 
 
 
ACKNOWLEDGEMENTS 
 
1. To the University of the Witwatersrand Ethics Committee for approving my research 
2. To Prof. A. Stewart and my supervisors, Prof. W. Mudzi and Dr. V. Ntsiea for your 
ongoing support, encouragement and patience in allowing me to perform research in 
a field very close to my heart. 
3. To Mrs. N. L. Mocwaledi-Senyane (Chief Executive Officer) and Dr. T. G. K. 
Oosthuizen (Senior Manager of Medical Services) of Witrand Hospital, 
Potchefstroom, for allowing me to base my study at their hospital and providing 
approval to use hospital data on which my study is based. 
4. To my colleagues at Witrand Hospital, thank you for your encouragement. 
5. To Edelweiss Janse van Rensburg, the rest of my family and Jolita Jansen van 
Rensenburg, your belief in me when I didn’t have the courage or strength to believe in 
myself has helped make my dream a reality. I will forever be indebted to you. 
6. To God be the Glory 
vii 
 
 
TABLE OF CONTENTS         Page Number 
 
DECLARATION            ii 
DEDICATION            iii 
ABSTRACT             iv 
ACKNOWLEDGEMENTS           vi 
TABLE OF CONTENTS           vii 
LIST OF APPENDICES           x 
LIST OF FIGURES            xi 
LIST OF TABLES            xii 
ABBREVIATIONS USED           xiii 
CHAPTER 1             1 
1. INTRODUCTION           1 
1.1. Background           1 
1.2. Problem Statement          3 
1.3. Research Question          3 
1.4. Aim of Study           3 
1.5. Objectives of the Study          3 
1.6. Significance of the Study         4 
1.7. General Outline of Research Report        4 
CHAPTER 2             5 
2. LITERATURE REVIEW          5 
2.1. Introduction           5 
2.2. Pathophysiology and Classification of HIV/AIDS      6 
2.3. Epidemiology of HIV/AIDS           10 
2.3.1. Sub-Saharan Africa          11 
viii 
 
 
2.3.2. South Africa           11 
2.3.3. North-West Province         11 
2.4. Impact of HIV/AIDS on the Individual and the Community    11 
2.5. Definition and Classification of Stroke       14 
2.6. Epidemiology of Stroke          16 
2.7. Aetiology and Risk Factors of Stroke        19 
2.8. Impact of Stroke on the Individual and the Community     24 
2.9. Rehabilitation Approach to Individuals with Stroke and HIV/AIDS   27 
2.10. Summary of Literature Review        31 
CHAPTER 3             33 
3. METHODOLOGY           33 
3.1. Introduction           33 
3.2. Study Design           33 
3.3. Setting            33 
3.4. Sample Selection and Size         34 
3.4.1. Inclusion Criteria          34 
3.4.2. Exclusion Criteria          34 
3.5. Procedure            35 
3.5.1. Ethical Considerations         35 
3.5.2. Pilot Study           35 
3.5.2.1. Objectives of the Pilot Study       35 
3.5.2.2. Methodology of the Pilot Study       35 
3.5.2.3. Results of the Pilot Study        36 
ix 
 
 
3.5.2.4. Discussion and Conclusion of the Pilot Study Results    36 
3.5.2.5. Main Study          36 
3.6. Instrumentation and Outcome Measures       38 
3.7. Data Analysis           40 
CHAPTER 4             41 
4. RESULTS            41 
4.1. Introduction           41 
4.2. Demographics and Clinical Characteristics of the Study Group   41 
4.3. Functional Abilities of Patients on Admission and at Discharge   45 
CHAPTER 5             46 
5. DISCUSSION            46 
5.1. Introduction           46 
5.2. Study Group’s Gender, Age, HIV status, CD4 Count, Length of Stay and Stroke 
Duration            46 
5.3. Study Group Demographics and Clinical Characteristics    47 
5.4. Functional Abilities of Patients        48 
5.5. Limitations            50 
CHAPTER 6             51 
6. CONCLUSION AND RECOMMENDATIONS       51 
6.1. Conclusion            51 
6.2. Recommendations          52 
REFERENCES            53 
 
 
x 
 
 
  
LIST OF APPENDICES 
 
Page 
Appendix A: Ethical Clearance Certificate 63 
Appendix B: Letter for Approval to Perform Study at Witrand Hospital 64 
Appendix C: Demographic Questionnaire 65 
Appendix D: Coding Sheet 66 
Appendix E: Beta Scoring Sheet 67 
xi 
 
 
LIST OF FIGURES  Page 
 
Figure 3.1: Study group (n) = 141 37 
Figure 4.1: Study group’s gender, HIV status and CD4 count 42 
 
xii 
 
 
         
 
LIST OF TABLES 
 
Page 
Table 2.1: Classification system for HIV infected individuals (Centres for  Disease Control 
and Prevention, USA) 
8 
Table 2.2: Clinical staging and disease classification system for HIV infected individuals 
(WHO) 
8 
Table 2.3: Prevalence of ICF domains affected by HIV as reported by cohort in British 
Columbia 
13 
Table 2.4: Risk Factors of Stroke 21 
Table 2.5 Predictors of Stroke Prognosis 25 
Table 3.1: Result of pilot study 36 
Table 3.2: The beta scoring system 39 
Table 3.7.1: Data variables 40 
Table 4.1: Study group demographics and clinical characteristics: Categorical variables 43 
Table 4.2: Study group demographics and clinical characteristics: Continuous variables 44 
Table 4.3: Functional ability represented by mean beta score 45 
 
xiii 
 
 
ABBREVIATIONS USED 
 
UN            United 
NationsAIDS         Acquired Immundeficiency 
Syndrome 
HIV         Human Immunodeficiency Virus 
WHO          World Health Organisation 
HAART        Highly Active Antiretroviral Therapy 
cART        Combination Antiretroviral Therapy           
TIA         Transcient Ischaemic Attack                
PAH         Pulmonary Arterial 
HypertensionARV’s           
 AntiretroviralsCDC          Centre for 
Disease Control              
ART           Antiretroviral Therapy 
DVT           Deep Vein Thrombosis   
HAD          HIV-Associated Dementia               
SADFM      South African Database for Functional Medicine 
ICF     International Classification of Functioning, Disability and Health 
D.O.A           Date of Admission 
D.O.BDate of Birth 
D.O.IDate of Incident 
L.O.SLength of Stay 
RxTreatment 
HPTHypertension 
DMDiabetes Mellitus 
1 
 
 
CHAPTER 1 
 
1. INTRODUCTION 
1.1 Background and Need 
Stroke is a significant contributor to disease worldwide (Cadilhac et al., 2010) and is the 
second highest cause of death in both men and women (Stuart-Sho et al., 2009). It is 
not only a common cause of mortality but also of morbidity. In general, stroke incidence 
is higher in Sub-Saharan Africa than in developed countries (Ogeng’o et al., 2010). 
Hypertension, diabetes, obesity and hypercholesterolemia are known risk factors of 
stroke to which prevention has been focussed; however, viral infections appear to be an 
emerging risk factor of stroke (Nagel et al., 2010).Recovery post-stroke involves 
complex rehabilitation and thus differs from person to person. Neurological recovery 
occurs mainly within 1-3 months post stroke, whilst functional recovery occurs more fully 
at 4-6 months (Schaechter, 2004). The coexistence of psychosocial and cognitive 
impairments, as well as a broad range of other neurological and sociodemographic 
factors has been seen to affect the functional recovery of stroke survivors (Saxena et 
al., 2006). The main objective in stroke rehabilitation is seen as aiding the patient to 
achieve their highest physical and psychological performance, with the ultimate goal of 
a stroke survivor being one of functional independence allowing them to return to their 
home and reintegrate back into their community (Kwakkel et al., 2004). 
 
There are 35 million people living with HIV of which 24.7 million are living in Sub-
Saharan Africa (The Gap Report, 2014). New HIV infections are declining however, with 
only 2.1 million new infections in 2013. This is a 38% decline from 2001 (The Gap 
Report, 2014). Almost half of all people living with HIV know their status (The Gap 
Report, 2014). Approximately 86% of people living with HIV who know their status in 
Sub-Saharan Africa are receiving antiretroviral therapy (The Gap Report, 2014). South 
Africa is regarded as having the world’s largest population of people living with AIDS, 
with a prevalence of 18% recorded by the World Health Organisation (Global Report, 
2013). An estimated 2.1 million individuals became infected with HIV in 2013 worldwide 
(The Gap Report, 2014).An individual with HIV will go through periods of both wellness 
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and illness, but HIV will always have a physical, psychological and social impact (Rusch 
et al., 2004).  
 
There is a greater prevalence of cerebrovascular risk factors in Human 
Immunodeficiency Virus (HIV)infected individuals (Foley et al., 2010). This increase is 
believed to be caused by the negative effects of antiretroviral therapy, increasing age 
and the direct impact of the HIV itself (Foley et al., 2010). Early onset atherosclerosis, 
diabetes, lipodystrophy, hypertension and myocardial infarcts have been linked to 
treatment with antiretroviral drugs (Qureshi, 2005). Neurological symptoms are the first 
manifestation of HIV infection in 10% - 20% of patients (Mochan et al., 2003). Within the 
HIV infected population, stroke affects male to females at a ratio of 1.5:1 with a mean 
age of 32.1 years in the female population. Ninety four percent of these strokes are 
cerebral infarcts and 6% are intracranial cerebral haemorrhages with a younger 
population being affected by HIV (Mochan et al., 2003). 
 
Depression is often seen in patients with HIV with statistics showing that approximately 
60% suffer from this disease. Motivational levels to participate in the rehabilitation 
process could be affected due to this (Dudgeon et al., 2004). Patients with HIV are 
treated using Highly Active Antiretroviral Therapy (HAART) whoseside-effects could 
indirectly affect their quality of life (Dudgeon et al., 2004). This may be as a result of 
wasting syndrome which is defined as involuntary loss of weight equivalent to less than 
10% of their baseline body weight in addition to prolonged fever, chronic weakness and 
chronic diarrhoea (Dudgeon et al., 2004). This leads to a significant loss of tissue, 
muscular strength and functional recovery (Dudgeon et al., 2006).  
 
A large number of individuals infected with HIV are also found to suffer from anaemia 
resulting in weakness and fatigue (Dudgeon et al., 2004). All co-morbidities mentioned 
could result in reduced energy levels, weakness and poor motivation, thus affecting the 
individual’s recovery.In the context of this study, the term ‘recovery’ should be 
understood as the regaining or possibility of regaining function that was lost. In a study 
done by Hama et al. (2007), depression and apathy were found to be predictors of poor 
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functional recovery post-stroke.   Fang et al. (2003) found that early prediction of 
functional recovery is an important factor in planning rehabilitation resources.It is at this 
point that the term ‘functioning’ be defined, using the ICF framework, as: “an umbrella 
term for body function, body structures, activities and participation. It denotes the 
positive or neutral aspects of the interaction between a person’s health conditions and 
that individual’s contextual factors (environmental and personal factors)” (WHO, 2001). 
Therefore the aim of this study was to determine the differences in functional status 
between patients with stroke who are HIV positive and those who are HIV negative. 
 
1.2 Problem Statement 
HIV is quite prevalent in our society and affects many individuals within the working age 
population. No studies have been done to determine if there are any differences in 
functional recoverybetween patients with stroke who are HIV positive and those who are 
HIV negative.  
 
1.3 Research Question 
What is the difference in functional recoverybetween patients with stroke who are HIV 
positive and those who are HIV negative? 
 
1.4 Aim of the study 
To describe the differences in functional abilitiesbetween patients with stroke who are 
HIV positive and those who are HIV negative admitted to Witrand rehabilitation unit in the 
North-West province of South Africa. 
 
1.5 Objectives of the study 
1.5.1 To describe the population demographics and clinical characteristics of 
patients with stroke admitted to the Witrand rehabilitation unit. 
 
1.5.2 To establish and compare the functional abilities of patients who are HIV 
positive with those who are HIV negative on admission to the Witrand 
rehabilitation unit. 
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1.5.3 To establish and compare the functional abilities of patients who are HIV 
positive with those who are HIV negative on discharge from the Witrand 
rehabilitation unit. 
1.5.4 To compare the functional change in ability of patients who are HIV 
positive and those who are HIV negative on discharge from Witrand 
rehabilitation unit 
 
1.6 Significance of the study 
Determining the differences in functional recovery between patients with stroke who are 
HIV positive and HIV negative will provide valuable information regarding a more effective 
distribution of resources to rehabilitation units. If patients who are HIV positive are found to 
be less functional compared to those who are HIV negative given the known physiological 
effects of the disease on the body, this could affect length of inpatient rehabilitation stay, 
number of post-discharge follow-up sessions and applications for disability grants. This 
study may highlight the areas that need further attention from healthcare providers to 
optimise rehabilitation outcomes among this group of patients. 
 
1.7 General Outline of Research Report 
The general outline of this research report is given below: 
 Chapter 2: Literature review 
 Chapter 3: Methodology 
 Chapter 4: Results 
 Chapter 5: Discussion 
 Chapter 6: Conclusion and recommendations 
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CHAPTER 2 
 
2. LITERATURE REVIEW 
2.1 Introduction 
Essentially this report focuses on the differences in functional recovery between patients 
with stroke who are HIV positive and those who are HIV negative. The individuals within 
the study group all have one thing in common in that they have suffered a stroke and the 
differing factor is that of the existence or non-existence of the HIV. The treatment and care 
of an individual that has suffered a stroke requires specialised care and resources. 
Unfortunately in South Africa where an estimated 120 neurologists exist for a population of 
30 million our resources are stretched very thin (Fritz, 2006). Only ± 10 – 20% of the 
population have access to rehabilitation units and with general stroke knowledge being 
poor in the country, complete rehabilitation is not often available (Fritz, 2006). So the 
question remains, how do we provide for these two chronic illnesses often in co-existence?  
 
This literature review has been developed to allow the researcher to gain an in-depth view 
of the study matter and material already discussing this conundrum to provide an 
understanding and knowledge to help ensure that the study is supported and enriched with 
value that will provide others with further information and findings regarding this field. In 
doing so the following search engines and databases were used: Google Scholar, EBSCO 
Host (Medline, Academic Search Complete, CINAHL Plus, Education Research Complete, 
ERIC, Global Health, Health Source: Nursing/Academic Edition, SocINDEX).  
 
The literature review was done under the following subheadings: 
2.2 Pathophysiology and classification of HIV/AIDS 
2.3 Epidemiology of HIV/AIDS 
2.4 Impact of HIV/AIDS on the individual and the community 
2.5 Definition and classification of stroke 
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2.6 Epidemiology of stroke 
2.7Aetiology and risk factors of stroke 
2.8Impact of stroke on the Individual and the community 
2.9 Rehabilitation approach to individuals with stroke and HIV/AIDS 
2.10 Summary of Literature Review 
 
2.2 Pathophysiology and Classification of HIV/AIDS 
Clinical characteristics of AIDS were first identified by scientists from the United States 
of America in 1981 (www.avert.org, 2012). The HIV which causes AIDS was only 
discovered two years later in 1983 (www.avert.org, 2012). The HIV/AIDS epidemic has 
now spread to every corner of the globe. 
 
Senocak et al. (2010) found HIV to originate from a group of viruses known as 
retroviruses, or more simply put – slow viruses as the time from initial infection to the 
appearance of clinical symptoms can take years. This means that the effects of the 
virus can remain undetected until the patient is eventually diagnosed with advanced 
AIDS, the end or last stage of the HIV disease. 
 
The workings of the HIV is very specific in nature. Upon entering the blood stream it 
primarily infects a group of immune cells known as activated CD4+ lymphocytes and 
begins to replicate rapidly, secondarily it also infects the macrophages that are also 
important role players in the body’s immune system (Ellis et al., 2009). Although infected 
macrophages are far fewer in number than the already mentioned lymphocytes, they are 
still considered as being important in the composition of the central nervous system (Ellis 
et al., 2009).  
 
Despite its global effects on the body, it is most often central nervous system 
abnormalities that are considered as the first signs of infection (Ellis et al., 2009). HIV can 
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cause central nervous system diseases in one of two ways:  
 
a) through primary HIV central nervous system diseases for which the virus is 
actually necessary and sufficient. 
b) through secondary central nervous system diseases which require an 
opportunistic pathogen that can take advantage of progressive immune 
deficiency (Ellis et al., 2009). 
 
HIV does not directly infect neurons, but rather causes damage indirectly by infecting 
macrophages and other cells (Ellis et al., 2009; Mochan et al., 2003). The onset of 
opportunistic infections such as tuberculosis is also a common first clinical sign of 
HIV/AIDS.The HIV/AIDS is a progressive disease often moving through various stages 
unbeknownst to the infected individual. At present there is no cure for HIV/AIDS 
therefore treatment has been aimed at halting the replication of this retrovirus at various 
stages in its life-cycle (Ellis et al., 2009). 
 
There are two main methods of classifying HIV as it progresses through its various stages. 
The classification systems used are that of the WHO and United States Centres for 
Disease and Prevention,but the WHO classification system appears to be the most user 
friendly and stands to be the most popular system. 
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Below are the two classification systems: 
 
Table 2.1:Classification system for HIV infected individuals (Centres for Disease 
Control and Prevention, USA) 
 
 
 
 
 
 
 
 
A 
Abbreviation PGL = persistent generalized lymphadenopathy 
(Adapted from www.aidsetc.org, 2012) 
 
The CDC assesses the severity of HIV by taking into account the CD4+ count as well as 
the presence of very specific HIV-related conditions (see below). It was revised in 1993. It 
is quite an intricate way of classification requiring CD4+ counts and other diagnostic test 
results. 
 
Table 2.2:Clinical staging and disease classification system for HIV infected 
individuals (WHO) 
Primary HIV Infection 
Asymptomatic 
Acute retroviral syndrome 
Clinical Stage 1 
Asymptomatic 
Persistent generalized lymphadenopathy 
Clinical Stage 2 
Moderate unexplained weight loss (<10% of presumed or measured body weight) 
Recurrent respiratory infections (sinusitis, tonsillitis, otitis media, and pharyngitis) 
Herpes zoster 
Angular cheilitis 
Recurrent oral ulceration 
CD4 Cell Categories Clinical Categories 
 A 
Asymptomatic, Acute HIV, 
or PGL 
B* 
Symptomatic Conditions, 
not A or C 
C
#
 
AIDS-Indicator 
Conditions 
(1) ≥500 cells/mm³ A1 B1 C1 
(2) 200-499 cells/mm³ A2 B2 C2 
(3) <200 cells/mm³ A3 B3 C3 
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Papular pruritic eruptions 
Seborrheic dermatitis 
Fungal nail infections 
Clinical Stage 3 
Unexplained severe weight loss (>10% of presumed or measured body weight) 
Unexplained chronic diarrhea for >1 month 
Unexplained persistent fever for >1 month (>37.6ºC, intermittent or constant) 
Persistent oral candidiasis (thrush) 
Oral hairy leukoplakia 
Pulmonary tuberculosis (current) 
Severe presumed bacterial infections (e.g., pneumonia, empyema, pyomyositis, bone or joint infection, 
meningitis, bacteremia) 
Acute necrotizing ulcerative stomatitis, gingivitis, or periodontitis 
Unexplained anemia (hemoglobin<8 g/dL) 
Neutropenia (neutrophils <500 cells/µL) 
Chronic thrombocytopenia (platelets <50,000 cells/µL) 
Clinical Stage 4 / AIDS 
HIV wasting syndrome 
Pneumocystis pneumonia 
Recurrent severe bacterial pneumonia 
Chronic herpes simplex infection (orolabial, genital, or anorectal site for >1 month or visceral herpes at any 
site) 
Esophageal candidiasis (or candidiasis of trachea, bronchi, or lungs) 
Extrapulmonary tuberculosis 
Kaposi sarcoma 
Cytomegalovirus infection (retinitis or infection of other organs) 
Central nervous system toxoplasmosis 
HIV encephalopathy 
Cryptococcosis, extrapulmonary (including meningitis) 
Disseminated nontuberculosis mycobacteria infection 
Progressive multifocal leukoencephalopathy 
Candida of the trachea, bronchi, or lungs 
Chronic cryptosporidiosis (with diarrhea) 
Chronic isosporiasis 
Disseminated mycosis (e.g., histoplasmosis, coccidioidomycosis, penicilliosis) 
Recurrent nontyphoidal Salmonella bacteremia 
Lymphoma (cerebral or B-cell non-Hodgkin) 
Invasive cervical carcinoma 
Atypical disseminated leishmaniasis 
Symptomatic HIV-associated nephropathy 
Symptomatic HIV-associated cardiomyopathy 
Reactivation of American trypanosomiasis (meningoencephalitis or myocarditis) 
 
(Taken from www.aidsetc.org, 2012) 
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The WHO classification system (revised in 2007) can be easily used in resource-
constrained settings without requiring access to the CD4+ cell counts or other diagnostic 
test results. The infected individual is classified purely on clinical manifestations. This 
method is used by many countries to determine initiation of Anti-retroviral therapy. 
 
2.3Epidemiology of HIV/AIDS 
Over the past 3 years alone, new HIV infections have fallen by 13% (The Gap Report, 
2014). Approximately 86% of people living with HIV who know their status in Sub-
Saharan Africa are receiving antiretroviral therapy (The Gap Report, 2014). More than 
five million individuals in low and middle income countries have been receiving this 
therapy since 2004 (Global Report, 2010). Thirty fivemillion individuals were living with 
HIV globally at the end of 2012, of which 24.7 million were adults (15 – 49 years of age) 
living in Sub-Saharan Africa (The Gap Report, 2014). Sub-saharan Africa remains the 
most severely affected region with ± 1 in every 20 adults (4.9%) living with HIV, and thus 
accounts for 71% of all individuals living with HIV worldwide (The Gap Report, 2014). 
Regions most heavily affected, following Sub-Saharan Africa, are the Caribbean, Eastern 
Europe and Central Asia(Global Report, 2012).  
In 33 countries there has been more than a 38% fall in HIV incidence from 2001 (The 
Gap Report, 2014). Countries in Sub-Saharan Africa account for 22 out of the 33 
countries. Countries such as Ethiopia, Nigeria, South Africa, Zambia and Zimbabwe have 
begun to show signs of stabilisation or decline in HIV incidence (Global Report, 2010). 
The sharpest declines have been observed in the Caribbean (42%) and Sub-Saharan 
Africa (25%). 
But all is not well globally. The number of newly infected individuals is declining globally, 
but national epidemics continue to expand in areas of the world (Global Report,2012). In 
seven countries, five of which are in Eastern Europe and Central Asia, HIV incidence has 
increased by more than 25% between the years 2007 and 2009 (Global Report, 2010). 
Since 2001 the number of newly infected individuals in the Middle East and North Africa 
has risen by more than 35% (Global Report, 2012). The number of annual AIDS-related 
deaths worldwide has fallen by 35% since 2005 (The Gap Report, 2014). 
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Below is a summary of the HIV/AIDS epidemic according to various regions as taken 
from the UNAIDS factsheets from their Global Report for 2010 and 2012, ‘The Gap 
Report 2014’ as well as a study on South African National Burden of disease study– The 
North-West Provincial profile(2000): 
2.3.1Sub-Saharan Africa 
It was noted that the HIV incidence is stable or declining. South Africa experienced a 
decrease in new HIV infections by > 25% over the period 2001 – 2009. HIV prevalence 
in West and Central Africa remained low in 2009, at or under 2% in twelve countries. An 
estimated 24.7 million individuals with HIV resided in Sub-Saharan Africa in 2013; this 
figure represents ± 71% global HIV burden.  
 
2.3.2 South Africa 
South Africa continues to have the world’s largest HIV epidemic with an estimated 5.6 
million individuals living with HIV. The prevalence of HIV varies greatly across the nine 
provinces. The highest rate is found in KwaZulu Natal which remained stable at 39.5% 
for 2009 and 2010. However, the number of new infections overall for 2011 in 
individuals older than fifteen years old was 316 900. 
2.3.3 North-West Province 
The North-West province makes up 6.43% of the South African population. In adults (49 
– 59 years of age) HIV/AIDS was responsible for the largest number of deaths in men 
and second largest cause of death in women. 
 
2.4Impact of HIV/AIDS on the Individual and the Community 
HIV has both a clear physical impact on the body as well as a psychological impact. In as 
much as the title of this study focuses on the physical effects of HIV, for physical 
rehabilitation we need an individual that can actively partake in the rehabilitation process 
thus requiring adequate cognitive functioning. Literature covering both areas was thus 
studied. One of the most visible signs of HIV is that of the wasting syndrome (Dudgeon et 
al., 2006), defined as: “involuntary weight-loss of more than 10% baseline body weight in 
addition to prolonged fever, chronic weakness, & chronic diarrhoea”. This is one of the 
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physiological effects of the virus and may include a high prevalence of anaemia, up to 
28% in this population. This negatively impacts on patients’ rehabilitation as they are 
physically weak (Rusch et al., 2004). 
 
Furthermore the virus may have an impact on the digestive tract (Dudgeon et al., 2006), 
leading to a high prevalence of gastrointestinal disorders in the HIV infected group. The 
virus itself also has the ability to cause atrophy of the digestive tract villi and thus reduce 
the surface area through which absorption takes place. This can easily result in diarrhoea 
and may worsen the symptoms of dehydration (Dudgeon et al., 2006; Rusch et al., 
2004). Swallowing disorders can be present in up to 47% of infected individuals. In this 
case, they have a decreased ability to chew and swallow food. Some individuals also 
seem to struggle in performing activities of daily living due to poor nutrition (Dudgeon et 
al., 2006). Swallowing may become painful, oral and oesophageal lesions may cause 
dysphagia and anorexia purely through the blocking of the glottis and reducing the size of 
the oesophagus. All of this could result in severe fatigue and a reduced functional ability 
for the individual to complete some common activities of daily living such as preparing 
meals or even shopping for healthy food options (Dudgeon et al., 2006; Rusch et al., 
2004). 
 
Cognitive impairments have been recognised as a symptom of HIV (Robinson – Papp et 
al., 2008) and neurological symptoms are often the first manifestation of the disease 
(Mochan et al., 2003). Human immunodeficiency virus – associated neurocognitive 
disorders are characterised by a triad of cognitive, behavioural and motor dysfunction 
(Ances et al., 2008; Woods et al., 2009). The ability to distinguish the cognitive outcomes 
of being infected by HIV from other co-morbidities is becoming problematic. However, 
Robinson-Papp et al. (2008)’s study showed that motor and behavioural abnormalities 
are associated with and can help predict cognitive impairments in an infected individual. 
Some of these cognitive impairments include: loss of concentration, distractibility and 
repetitive reminders(Moore et al., 2011; Ances et al., 2008). These may encroach on 
activities of daily living making them laborious. The HIV positive population also has an 
increased incidence of anxiety and depression, which reduces motivation and drive in an 
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individual if undertaking rehabilitation with the added negative effect on drug adherence 
leading to faster disease progression (Dudgeon et al., 2006). 
 
Ances et al. (2008) listed common motor symptoms which include: slowed repetitive 
movements, clumsiness, unsteady gait, and balance problems; as well as neurological 
disturbances such as those caused by central nervous system tumours, dementia, 
myelopathy, painful sensory neuropathy and myopathy (Mochan et al., 2003).  
 
With the introduction of anti-retroviral therapy HIV related patient mortality has reduced 
but this life extending treatment has severe side-effects which could also affect their 
quality of life (Dudgeon et al., 2004). Rusch et al. (2004) identified ‘cycles of illness and 
wellness’ for those on treatment, but more importantly found that infected individuals’ 
quality of life was affected in physical, psychological and social spheres of life. 
 
Rusch et al. (2004) did a questionnaire based study using the International Classification 
system in British Columbia to investigate the presence and severity of impairments, 
activity limitations, and participation restrictions within this population group. The results 
are tabulated below: 
 
Table 2.3:Prevalence of ICF domains affected by HIV as reported by cohort in British 
Columbia 
Impairment Activity Limitation Participation Restriction 
Mental Health disorders 
(62.9%) 
Mental Impairment (78.2%) 
Sensory Impairment (71.9%) 
Neuromuscular Impairment 
(49.5%) 
Internal Impairment (81%) 
Vigorous and moderate 
activities, sexual activities 
and household  
chores were the most 
common. 
(80.6%) 
High for all CD4 categories but 
sexual roles, 
student/employee 
roles and financial roles were  
most prevalent. 
(93.2%) 
 
The most prevalent impairments experienced were diarrhoea (57.1%), reduced libido 
(55.8%), general weakness (48.2%), poor concentration (47%), chronic fatigue (46.6%) 
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and headaches (46.9%). Pain was reported by half of the population, and of this group > 
¾ had a CD4+ cell count of ≤ 200 cells / mm³. Moderate or severe pain was experienced 
by approximately 37.1% and little or mild pain by ± one third of the population (Rusch et 
al., 2004). This study also showed that categorisation into groups based on CD4+ cell 
counts did not reflect a relationship with the disability they experienced or their perception 
of their health. 
 
Earlier, the impact of stroke on the individual was discussed and there are many 
similarities seen between those and the impact of HIV on the individual. Strong 
similarities are found in the emotional and cognitive effects of these two diseases. There 
is a common finding of depression which effects the individual’s motivation and drive 
which in turn affects their desire to actively partake in the rehabilitation process. This is 
worsened by HIV as itresults ina host of physiological co-morbidities such as wasting 
syndrome, anaemia and dehydration which physically results in patient lethargy and 
causing them to retreat from physical activity.  
 
2.5 Definition and classification of stroke 
The World Health Organisation (WHO) defines stroke (also known as a cerebrovascular 
accident/incident) as “rapidly developing clinical signs of focal, or at times global 
disturbance of cerebral function, lasting more than 24 hours or leading to death with no 
apparent cause other than a vascular origin” (WHO, 2002). Post stroke, brain tissue is 
damaged due to a lack of oxygen and nutrients to the brain (WHO, 2002).  
 
There are two main types of stroke which are ischaemic and haemorrhagic stroke. 
Ischaemic stroke occurs from a blocked artery while haemorrhagic stroke occurs from a 
burst artery or vein. Over two-thirds of strokes are of an ischaemic nature, affecting either 
small vessels or large vessels (Chestnut, 2011). Small vessel blockages result in lacunar 
infarcts that present with a specific clinical syndrome, but with better functional status and 
prognosis post-stroke versus large vessel blockages, which affect a wider area of cerebral 
cortical impairment (Chestnut, 2011). 
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It is well documented that ischaemic strokes occur more frequently than haemorrhagic 
strokes within the general population (Lee et al., 2011;Turanjanin et al., 2011;Spengos and 
Vemmos, 2010; Appelros et al., 2009; Cabral et al., 2009). What we are still trying to 
understand more are HIV-associated strokes. Benjamin et al. (2012) looked into current 
perspectives of stroke in HIV positive individuals and found that ischaemic strokes were 
more common in HIV positive individuals with stroke. A longitudinal study done in the 
United States from 1997 to 2006 confirmed that the number of patients with stroke who 
were HIV positive increased dramatically by 43% and this coincided with the introduction of 
combination antiretroviral therapies (cART) in the mid 1990’s (Benjamin et al., 2012). 
Benjamin et al. (2012) made a solid statement when they commented on ischaemic 
strokes appearing more frequently in HIV positive patients than the haemorrhagic type in 
hospital-based studies performed in Sub-Saharan Africa. This is supported by findings 
from research performed by Longo-Mbenza et al., 2011;OvbiageleandNath, 2011;Oritz et 
al., 2007; Tipping et al., 2007; Qureshi, 2005.  
 
Ovbiagele and Nath (2011) also made note that there was a ± 67% rise in proportion of 
patients hospitalised for ischaemic stroke who were HIV positive in the United States, the 
number of patients more than doubled between the years 1997 and 2006. A study based 
at Groote Schuur Hospital, Cape Town, South Africa; identified 42% of their HIV positive 
study participants’ first ever stroke was in fact the clinical event which resulted in their 
initial diagnosis of HIV (Tipping et al., 2007). The ischaemic and haemorrhagic relationship 
followed the general trend at 96% versus 4%. 
 
The HIV-associated ischaemic stroke risk factor profile differed significantly from the 
general population as hypertension, diabetes, hypercholesterolemia and smoking were not 
significant risk factors (Tipping et al., 2007). In fact infections were found to be the most 
common cause, accounting 28% of the ischaemic strokes. There are various mechanisms 
that could result in ischaemic stroke in the HIV positive group, such as: opportunistic 
infections in immune-compromised individuals, vasculopathies, cardioembolisms and 
coagulopathies (Benjamin et al., 2012; Longo-Mbenza et al., 2011; OvbiageleandNath, 
2011;Oritz et al., 2007; Tipping et al., 2007;Qureshi, 2005). Along with these mechanisms, 
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to be discussed in greater detail at a later stage, the global use of cART in HIV positive 
patients increases life expectancy and thus their risk for an ischaemic stroke due to its high 
correlation with age (Obviagele and Nath, 2011). 
 
Care should be taken not to confuse stroke with a Transient Ischaemic Attack (TIA).The 
American Heart Association/American Stroke Association endorsed definition of a TIA as 
follows: “TIA is a transient episode of neurological dysfunction caused by a focal brain, 
spinal cord, or retinal ischaemia without acute infarction” (Nentwich et al., 2012). Despite 
the lack of permanent brain damage, TIA’s are a serious warning sign of stroke. The 
aetiology of a TIA is similar to that of a full blown ischaemic attack, with the difference lying 
in the fact that the blockage of the blood vessel is not permanent and clears sporadically. 
The blockage can be a result of one of three causes: (1) low blood flow at a narrow part of 
a major artery carrying blood to the brain, (2) blood clot in another part of the body breaks 
off, travels to the brain and blocks a blood vessel in the brain, (3) narrowing of smaller 
blood vessels in the brain, blocking blood flow for a short period of time, usually caused by 
plaque build-up (www.stroke.org, 2012). 
 
2.6 Epidemiology of Stroke 
By 1990, stroke was seen as the commonest cause of mortality worldwide, totalling 
approximately 4.4 million deaths, two-thirds occurring in less developed countries, 
which would include South Africa (Modi, 2008). About 60% of all deaths in 2002 were 
due to stroke (Burke et al., 2006). Approximately 60% of global mortality resulted from 
stroke in 2002. Stroke was responsible for three million deaths in the East Asian Region 
(Burke and Venketasubramanian, 2006).  
 
Non-communicable diseases are a leading cause of global mortality resulting in 67% of 
all deaths the world over in 2008 (Smith Jr, 2011); the greatest increase occurring in 
low- and middle income countries. Stroke mortality has decreased in industrialized 
countries allowing for stroke-related disabilities to increase (Turanjanin et al., 2011; 
Bhalla et al., 2009; Tobias et al., 2007; Paul et al., 2007; Truelson et al., 2006). Stroke 
is also associated with expensive medical expenses, lost labour productivity and this 
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can all lead to family poverty (Wang et al., 2009). 
 
A study performed using young adults from Athens found that, compared to other 
studies, it is generally accepted that post-stroke functional outcome amongst the youth 
is good (Spengos and Vemmas, 2010). However, Lee et al. (2011) found that a minority 
of young Koreans returned to work post-stroke even after receiving treatment and 
management. In Brazil, Cabral et al. (2009), reported on patient presentation six months 
post-stroke and discovered the following: (1) 25% had died (2) 13.5% were fully 
dependent (3) 61.5% were living independently. According to WHO 2020 projections, 
stroke will remain the second most common cause of mortality worldwide (Stroebele et 
al.,2011; Turanjanin et al., 2011; Burke and Venketasubramanian, 2006) despite it 
being a highly preventable disease (Tobias et al., 2007). Developing nations are at 
different stages in the ‘epidemiologic health transition’. The epidemiologic health 
transition involves degenerative and chronic diseases replacing infectious pandemics as 
the primary causes of morbidity and mortality (Noah et al., 2011; Burke and 
Venketasubramanian, 2006). However, improved understanding and management of 
stroke has resulted in a decline in stroke mortality. From 1996 to 2006, stroke mortality 
fell by 33.5% and the actual number of stroke deaths declined by 18.4% (AHA, 2012). 
 
Hospital based surveillance studies were performed in Afghanistan and Nepal focussing 
on the risk factors of stroke (Bhalla et al., 2009). However hospital surveillance studies 
alone are not reliable as not all patients with stroke present to hospitals or stroke units 
(Canto-Brito et al., 2011; Spengos and Vemmas, 2010; Tobias et al., 2007). Canto-Brito 
et al. (2011) tried to overcome this challenge by performing a door-to-door capture of 
stroke cases in Mexico. A prevalence of probable/verified stroke of 7.7/1000 was found 
with a cumulative stroke incidence of 232.3/1000 (Canto-Brito et al., 2011). Burke and 
Venketasubramanian (2006) did a study in East Asia and found the following: out of 1 
321 733 individuals ≥ 35 years of age, 4995 were recorded as suffering a first ever 
stroke; the age and sex-standardised incidence ranged between 201 and 483. The 
incidence of Canto-Brito et al. (2011) study lies within the range of Burke and 
Venketasubramanian (2006)’s findings. Stroke incidence was also highly correlated with 
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increasing age (Carbal et al., 2009; Paul et al., 2007; Burke and Venketasubramanian, 
2006). 
 
Geographical components seem to have some form of influence in stroke incidence in 
China, Taiwan and Japan (Cabral et al., 2009; Burke and Venketasubramanian, 2006) 
with the average incidence in these countries being higher than Western Europe and 
the United States. Despite previous reports of ischaemic strokes occurring more 
frequently than haemorrhagic stroke, the opposite is found to be true in Asian countries 
(Burke and Venketasubramanian, 2006; Spengos and Vemmas, 2010; Lee et al., 2011).  
 
When researching incidence and prevalence of stroke, gender appeared to dominate 
data regarding incidence and prevalence; as well as the data regarding type of stroke 
suffered (Lee et al., 2011; Noah et al., 2011; Stroebele et al., 2011; Spengos and 
Vemmas, 2010; Appelros et al., 2009;Cabral et al., 2009; Tobias et al., 2007; Burke and 
Venketasubramanian, 2006). Incidence rates appear to be generally higher across all 
age groups in males than females, however, the stroke types suffered differ in that 
males show a greater tendency for ischaemic and intracerebral haemorrhages and 
females, subarachnoid haemorrhages (Lee et al., 2011; Turanjanin et al., 2011; 
Appelros et al., 2009;Cabral et al., 2009; Tobias et al., 2007; Truelsen et al., 2006).  
 
There also appears to be a dissimilarity in the ages of stroke onset between males and 
females (Spengos and Vemmas, 2010; Appelros et al., 2009; Lee et al., 2009;Tobias et 
al., 2007; Burke and Venketasubramanian, 2006). Tobias et al. (2007) found that the 
average male onset of stroke was 68.9 years and 73.3 years for females, with males 
having ± 20% higher prevalence rates than that of females (Tobias et al., 2007). 
Spengos and Vemmas (2010) reported that the mean age of onset for both genders 
was 36.9 ± 7.2 years, but care should be taken when comparing this study to Tobias et 
al. (2007) as Spengos and Vemmas (2010) only performed their study on a population 
aged 15 years to 45 years. Appelros et al. (2009) discovered that males are generally 
younger than females when they experience their first stroke, with females experiencing 
their first stroke, on average, 4.3 years later than men. 
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It is clear that non-communicable diseases still pose a great threat to the world over. 
The different aspects of stroke epidemiology touched on indicate that it is a disease that 
does not demonstrate bias and thus can be seen as a very real life altering disease. 
 
2.7 Aetiology and Risk Factors of Stroke  
Ischaemic and haemorrhagic strokes are heterogenous multifocal diseases and thus 
occur as a result of not one risk factor but many (Silverstrelli et al., 2006). The term ‘risk 
factor’ was defined by Turanjanin et al. (2011) as phenomena that lead to pathological 
changes over a period of time and significantly affect the absolute risk, i.e. the 
probability of getting a disease. In essence stroke is a lifestyle disease and many 
factors can increase or decrease stroke risk (Bhalla et al., 2009).  
 
There is insufficient literature on HIV and stroke to state direct causality between the 
two conditions. There is however enough data to claim that HIV can be associated with 
the cause of a stroke. Benjamin et al. (2012) proposed that HIV can lead to a stroke in 
one of two ways: 
 
i. Indirectly: cardioembolism, coagulopathy or non-infective vasculitis 
ii. Directly: HIV-associated vasculopathy 
Research by Benjamin et al. (2012) was supported by studies conducted by 
Ovbiagele&Nath (2011), Longo-Mbenza et al. (2011), Oritz et al. (2007), Tipping et al. 
(2007)and Qureshi (2005). Below is a summary of the proposed association between 
HIV and stroke identified by these researchers: 
 
(a) Coagulopathy 
HIV has the ability to predispose an individual to arterial or venous 
thrombosis, but to what extent is unclear. 
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(b) Cardioembolism 
It accounts for 4 – 15% of ischaemic strokes in individuals with HIV. HIV-
associated dilated cardiomyopathy is a frequently reported cause of cardiac 
disease, particularly in Sub-Saharan Africa. This disorder may be associated 
with opportunistic infections due to immunosuppression caused by HIV. 
However, the pathogenesis is uncertain. 
(c) Opportunistic infection 
Infections e.g. mycobacterium tuberculosis, syphilis and varicella zoster virus 
are well-known causes of stroke in HIV negative patients. HIV, however, 
causes immunosuppression thus increasing the individuals susceptibility to 
reactivation of infections. Combined antiretroviral therapy might also unmask 
other unknown opportunistic infections that subsequently cause stroke. 
(d) HIV-associated vasculopathy 
This is a relatively new term used to describe arterial changes associated with 
HIV infection. Researchers suggest that due to the uncertain nature of its 
pathogenesis of vasculitis, all arterial abnormalities thought to be associated 
with stroke should also be regarded as part of an HIV-associated 
vasculopathy. Human immunodeficiency virus infection can be associated 
with accelerated large-vessel atherosclerosis, potentially caused by cART and 
associated metabolic complications i.e. dyslipidaemia or diabetes (well-known 
modifiable risk factors in HIV negative individuals). 
It was also found that stroke risk is not only associated with HIV infection but also its 
treatment. Combined antiretroviral therapy can cause direct or indirect tissue injury to 
the arteries, but again this relevance is unknown. 
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Literature has grouped stroke risk factors into modifiable and non-modifiablerisks. 
Below is a table grouping the various risk factors (Stroebele et al., 2011): 
Table 2.4:Risk Factors of Stroke 
Modifiable Non-modifiable 
Hypertension 
Diabetes 
Smoking 
Dyslipidaemia 
Obesity 
Alcohol consumption 
Age 
Gender 
Family history 
 
 
Hypertension is the most important risk factor, affecting 80% of stroke survivors (Rigby 
et al., 2009) and 51.5% in a study by Lee et al. (2011). Untreated hypertension ranged 
24.9% to 33% (Cabral et al., 2009).This finding is important if we compare it to the 
number of individuals affected by hypertension. There appears to be a strong 
association between hypertension and resultant ischaemic strokes (Lee et al., 2011; 
Noah et al., 2011; Turanjanin et al., 2011; Spengos and Vemmas et al., 2010; Cabral et 
al., 2009). The risk of developing an ischaemic stroke in individuals with hypertension is 
estimated to be 3 to 4-fold greater (Turanjanin et al., 2011). When vascular risk factors 
were considered, hypertension was again considered as a strong predictor for stroke 
(Smith Jr, 2011). Different risk profiles were found between the genders, with a greater 
number of females having hypertension as a risk, but the researchers could not 
confidently say if this was due to biological or lifestyle differences (Dearborn and 
McCullough, 2009). Even in developing countries the future burden of stroke is likely to 
increase due to the increase in the prevalence of hypertension (Das et al., 2007). In 
rural Africa, hypertension was again found to be the most important risk factor of stroke 
(80%), however, the awareness of this fact needs to be improved through community 
education (Wasserman et al., 2009). 
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A study based in France concentrating on pulmonary arterial hypertension (PAH) 
established HIV as a risk factor for this subtype of hypertension. Pulmonary arterial 
hypertension results from the chronic obstruction of small pulmonary arteries, this then 
leads to right ventricular failure and eventually death (Sitbon et al., 2008).Males with 
HIV are more likely to be affected by PAH (Speich et al., 2001; Sitbon et al., 2008). Both 
studies cited above also found that the number of patients with CD4+ counts < 200 
cells/mm³ was found to be greater in these individuals with PAH. Speich et al. (2001) 
ascertained that those individuals with HIV-associated PAH had significantly poorer 
survival rates compared to a matched group of HIV individuals without PAH. 
 
Age was determined as the most important non-modifiable risk factor by Bhalla et al. 
(2009) in a study set in Nepal. This study found that in an aging population with an 
increased life expectancy there would be an increase in predisposition for stroke. In 
reading the available literature it would appear that age and gender go hand in hand 
and are thus reported on together. The incidence rates tend to be greater in males than 
females up until ≥ 75 years of age in which female incidence becomes greater than that 
of males (Truelsen et al., 2006), but regardless of gender the WHO estimates that 
stroke rates increase exponentially with age (Tobias et al., 2006; Truelsen et al., 2006). 
Research in a developing country Das et al. (2007) found 20 individuals in his study 
group suffered a first time stroke before 40 years of age which leaves a rather 
conflicting picture of stroke regarding the age of onset. But again in a developed 
country, such as New Zealand, the average age of stroke onset is ≥ 65 years of age 
(Tobias et al., 2007), thus the state of the country regarding its development should also 
be factored in. It is often seen that age will also have an influence on the presence of 
modifiable risk factors (Lee et al., 2011). A study by Lee et al. (2011) found that these 
risk factors differed significantly between the age group ≤ 49 years and ≥ 50 years 
population, but these findings will be discussed in chapter 4. 
 
Young et al. (2009) also found that individuals who are HIV positive are at a higher risk 
of developing diabetes. The processes identifying this relationship include (1) the pro-
inflammatory process of HIV, (2) direct effects of ARV’s and (3) the indirect outcomes of 
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ARV’s. The most influential indirect consequence of ARV use appears to be body fat 
distribution changes (Young et al., 2009). Increased fat deposition in the muscles occur 
which leads to impaired insulin sensitivity. Antiretroviral   regimens also impair glucose 
tolerance (Young et al., 2009). Wit et al. (2008) took a deeper look into the specific 
ARV’s; they found that the relationship between the development of new-onset diabetes 
and the use of Stavudine was significant and Zidovudine and Didanosine appeared to 
increase one’s likelihood of developing new-onset diabetes (Wit et al., 2008). 
Conversely exposure to Ritonavir and Nevirapine reduced one’s risk of acquiring new-
onset diabetes (Wit et al., 2008). 
 
Diabetes is also considered a modifiable risk factor. A significant association between 
stroke prevalence and diabetes was noted by Burke and Venketasubramanian 
(2006),yet in knowing this, there is still a low percentage of appropriate primary 
preventative treatment for diabetes, even in developed countries (SpengosandVemmas, 
2010). There appears to be no age discrepancy too as diabetes is a major risk factor for 
stroke in both young and old, but is seen more frequently in those ≥ 50 years of age and 
those of Asian and African decent (Lee et al., 2011). Turanjanin et al. (2011) specified 
that it was in fact diabetes type II that was seen as a major risk factor which becomes 
more so depending on the duration and presence of the disease, as well as if it is a co-
morbid along with hypertension. Diabetes type II (formerly called non-insulin-dependent 
or adult-onset diabetes) is defined by the WHO (2013) as being caused by the body’s 
ineffective use of insulin. It often results from excess body weight and physical inactivity. 
Diabetes is a lifestyle related disease and therefore cannot be discussed without looking 
at obesity and dyslipidaemia as modifiable risk factors. 
 
Obesity and dyslipidaemia were reported as risk factors in a study by Bhalla et al. 
(2009). They recommended a cholesterol level of 200mg/dL for stroke prevention, but if 
it decreases below 180mg/dL there is a significant increase in risk of suffering a 
haemorrhagic stroke but the inverse, i.e. an increase in total cholesterol, increases the 
risk for an ischaemic stroke. Thus a very fine balance of the total cholesterol levels is 
extremely important. Dyslipidaemia was one of the most frequently found risk factors on 
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onset of ischaemic stroke at 41.1% (Spengos and Vemmas, 2010). Human 
immunodeficiency virus infection can be associated with accelerated large-vessel 
atherosclerosis, potentially caused by cART and associated metabolic complications i.e. 
dyslipidaemia(Benjamin et al., 2012).  
 
A study by Bhalla et al. (2009) based in Nepal found smoking to be the greatest 
modifiable risk factor within their study group at 58.3% with alcohol consumption in third 
place at 41.4%. Smoking was again found as a major risk factor in Spengos and 
Vemmas (2010) study at 59.3%, the most frequent risk at stroke onset. Smoking is seen 
in both young and old (Lee et al., 2011). Cigarette smoking independently increases the 
relative risk of stroke by ± 3-fold, with a prevalence of smoking in young adults with 
stroke in recent western studies between 44 – 47% (Lee et al., 2011; Turanjanin et al., 
2011). The Framingham study was referred to in Turanjanin et al. (2011) in which 
excessive but also moderate alcohol consumption in males is associated with an 
increase in relative risk of stroke. However, the consumption of small quantities is 
associated with a decrease in relative risk of stroke compared with those who do not 
drink at all (Turanjanin et al., 2011; Smith Jr et al., 2011). This could imply that a small 
quantity of alcohol is somewhat preventative against stroke incidence. 
 
2.8 Impact of Stroke on the Individual and the Community 
During the acute phase post stroke, the common impairments are motor function (50 – 
83%), cognitive functioning (50%) urinary incontinence (40 – 50%), dysphagia (45%), 
aphasia (23%) and dysphasia (36%)(Paul et al., 2007). This is further compounded by 
the fact that approximately half of all surviving stroke patients make incomplete recovery 
and half of them will require assistance with their activities of daily living (Wasserman et 
al., 2009; Truelson et al., 2006).These impairments lead to inability to carry out activities 
of daily living and hence caregivers suffer high levels of emotional strain and distress 
from looking after the stroke survivors (Paul et al., 2007). 
 
Stroke is a costly disease due to the nature of physical disability which often determines 
length of time in hospital (Wade and Hewer, 1987; Jongbloed, 1986). Wade and 
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Hewer(1987) performed a study in England focussing on the functional abilities of 
individuals post-stroke. The Barthel Activity of Daily Living Index was used as an 
outcome measure. A score of 20 implied functional independence but not necessarily 
normality. It must also be stressed that patients were scored on what they did and not 
their potential functional ability. A hierarchy amongst the tests was identified by Wade 
and Hewer (1987) i.e. at three weeks 50% of the patients that scored between one and 
nineteen could groom alone but only 14% could dress alone. They concluded that 
dressing unaided was one of the tasks that recovered relatively late in the rehabilitation 
process. 
Deficits in the upper limb and lower limb function are the most debilitating and persistent 
impairments seen post-stroke (Chauhan and Kumar, 2012). Eighty percent of all stroke 
survivors have gross and fine motor impairments with general balance problems, 
leading to poor recovery of activities of daily living and mobility (Chauhan and Kumar, 
2012).  
 
Jongbloed (1986) identified predictors that differ between stroke patients with good and 
poor prognoses. Below is a summary of these predictors identified. 
 
Table 2.5Predictors of Stroke Prognosis 
Predictor Outcome 
Age Data favours that older individuals have 
less functional outcomes 
Sex No difference found 
Previous stroke Negative relationship between previous 
stroke and functional outcome 
Urinary / Bowel incontinence Adverse prognosis on functional outcome 
Hemisphere of stroke No difference found 
(Jongbloed, 1986) 
 
The above table provides a clear guideline from which one can foresee discharge 
outcomes when a stroke survivor’s clinical characteristics are taken into account. A 
stroke survey by Wasserman et al. (2009) done in rural Kwa-Zulu Natal, South Africa, 
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found that upon discharge from hospital, 90% of the patients with stroke were bed or 
wheelchair bound (Wasserman et al., 2009). At the three month follow-up 55 % of the 
survivors were independently mobile compared to the 10% that were mobile on 
discharge. Most survivors did show some functional improvement, but their quality of life 
remained considerably impaired based on their self-assessment scores.  
 
Galski et al. (1993) identified that major depression or dysthymic disorders occur in 20% 
- 63% of stroke survivors in the acute phase or rehabilitation, and this could hamper the 
rehabilitation process. Not only can one’s mood become a challenge in recovery, but 
deficits in cognition could also negatively influence one’s rehabilitation. Deficits in 
cognitive abilities such as abstract thinking, judgement, short-term verbal memory, 
comprehension and orientation might affect a patient’s length of stay in the hospital and 
their functional status at discharge (Galski et al., 1993). A stroke survivor with cognitive 
deficiencies might not have the insight and capacity to learn new tasks and the ability to 
carry over functional skills from day-to-day. Thus a patient who excels in their physical 
rehabilitation may be less functional as a whole individual in their community due to 
cognitive disabilities that hold them back from interacting functionally in their community 
(Galski et al., 1993).  
 
Individual burden is not the only consequence of stroke. On a societal level it is 
responsible for a large portion of health costs (Paul et al., 2007). A considerable portion 
of all costs to patients with stroke is due to long-term care, rehabilitation, nursing and 
loss of production (Truelson et al., 2006). Clearly the burden does not lie in high 
mortality alone, but the high morbidity of stroke leaving up to 50% of survivors 
chronically disabled (Myles and Breyer, 2006).This burden is compounded by the fact 
that South Africa has limited resources for stroke care and rehabilitation facilities, 
especially to those who cannot afford private medical services (Rigby et al., 2009; 
Wasserman et al., 2009). 
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2.9Rehabilitation Approach to Individuals withstroke and HIV/AIDS 
The terms ‘multidisciplinary’ and ‘interdisciplinary’ are often mentioned when the 
rehabilitation of an individual who has suffered stroke is discussed. However there lies a 
great difference within the connotation of these terms. A sub-acute rehabilitation unit may 
consist of a ‘team’ made up of a multitude of differing professions but each working within 
their own scope of practice and not engaging together in approaching the case in a holistic 
manner (Norrefalk, 2003). Melvin (1980) further described ‘multidisciplinary’ as: “refers to 
activities that involve the efforts of individuals from a number of disciplines. These efforts 
are disciplinary-orientated and, although they may impinge upon clients or activities dealt 
with by other disciplines, they approach them primarily through each discipline relating to 
its own activities”.Whereas an ‘interdisciplinary’ team made up of many differing 
professionals communicate with one another on a regular basis to discuss a case and 
identify ways in which to assist each other and the patient in reaching their goals 
(Norrefalk, 2003). “Interdisciplinary team individuals do not only require the skills of their 
own disciplines, but also have the added responsibility of the group effort on behalf of the 
activity or client involved. This effort requires the skills necessary for effective group 
interaction and the knowledge of how to transfer integrated groups activities into a result, 
which is greater than the simple sum of the activities of each individual discipline. The 
group activity of an interdisciplinary team is synergistic, producing more than each 
individually and separately could accomplish” (Melvin, 1980). Fortunately the institution at 
which this study is based works on the basis of the latter approach and meet weekly to 
discuss each case in great detail and determine a means in which each team member, 
including the patient, can support one another in reaching the rehabilitation goals. In a 
study by Duncan et al. (2005) they confirmed that rehabilitation should be delivered in a 
coordinated and organised setting; therapy should be delivered by a variety of disciplines; 
and an organised team approach should also be continued in coordinating the out-patient 
or home-based rehabilitation care. 
Rehabilitation is a vital component of post-stroke care with up to two-thirds of survivors 
requiring rehab (Chestnut, 2011). There is a growing need for identifying barriers to an 
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efficient rehab service (Chestnut, 2011), and effective rehabilitation initiated early after 
stroke can help enhance the recovery process and minimise functional disability 
(Chauhan and Kumar, 2012; Duncan et al.,2005). This early initiation is based on 
physiological findings in which the second week post-stroke involves softening of an 
infarct, subsiding of oedema and vasculargrowth around the infarct (Chestnut, 2011). 
Post-stroke rehabilitation can begin during acute hospitalisation, once the diagnosis of 
stroke has been made (Duncan et al., 2005). It is during this phase in which the highest 
priorities of care include: (1) prevent recurrent stroke and complications, (2) ensure 
proper management of general health functions, (3) mobilise the patient, (4) encourage 
the resumption of self-care activities and (5) provide emotional support to the family and 
patient (Duncan et al., 2005).  
 
Recovery post-stroke can depend largely on type of stroke suffered and the existence of 
a co-morbid disease, and as previously discussed the effect of HIV on the body could 
hamper recovery severely (Chestnut, 2011). Putting HIV aside, the disabilities that 
transpire as a result of stroke can be devastating to the individual. Dobkin (2005) 
described these disabilities in one of his articles; approximately 35% of stroke survivors 
with initial paralysis of the effected leg do not regain useful function, 20 – 25% require 
full physical assistance to walk and ± 6 months post-stroke, 65% of stroke survivors 
cannot integrate the affected hand into usual activities. Finally, only 25% of stroke 
survivors return to the level of everyday participation and physical functioning of 
community matched individuals who have not suffered a stroke (Dobkin, 2005).  
 
In-patient rehabilitation was found to be most effective when the patient had adequate 
cognition and fitness to participate in treatment for three hours a day (Duncan et 
al.,2005; Dobkin, 2005). Duncan et al. (2005) stated that a patient’s tolerance for 
therapy will depend on several factors including severity of stroke, medical stability, 
mental status and level of function. Higher order cognitive skills such as short term 
memory, language, orientation, safety awareness, and judgement also play a major role 
in predicting a patient’s functional status at discharge.We now, however, need to take 
into account that some stroke survivors live with the co-morbid disease of HIV – causing 
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its own host of impairments on the body. A lot of the deficits caused as a result of stroke 
become compounded by the co-existence of HIV. Dudgeon et al. (2006) described 
wasting syndrome which leaves the individual with chronic weakness and anaemia. The 
effect that HIV has on the gastrointestinal tract could lead to dehydration and thus the 
patient’s condition is further weakened (Rusch et al., 2004). 
 
As mentioned previously, the ideal candidate for rehabilitation is one that has sufficient 
cognitive and physical fitness to tolerate the rehabilitation programme. Unfortunately 
HIV further affects the individual’s higher order cognitive skills by causing loss of 
concentration, distractibility and repetitive reminders (Moore et al., 2011; Ances et al., 
2008). Dudgeon et al. (2006) found that the HIV infectedpopulation have a high 
incidence of anxiety and depression and this could result in reduced motivation and 
drive that would hold back the rehabilitation process.  
 
Pain is also a very real and challenging symptom of HIV often resulting in painful 
sensory neuropathy and myopathy which, if not treated correctly, could lead to chronic 
pain and hamper participation in rehabilitation (Mochan et al., 2003). Lastly, the 
introduction of ARV’s (which does have life-extending outcomes)   can also have a 
negative impact on the patient. Rusch et al. (2004) confirmed that: 48.2% suffer from 
general weakness, 47% suffer from poor concentration and, 46.6% suffer from chronic 
fatigue. It is a vicious cycle. 
 
During the post-stroke training period, gross motor function improves at a faster rate as 
compared to fine motor, suggesting fine motor skills require more time to recover 
(Chauhan and Kumar, 2012). Despite all the above mentioned challenges, one must 
venture forward and not be discouraged by the cognitive or physical impairments of the 
stroke survivor. Duncan et al. (2005) support early mobilisation of a patient in order to 
prevent skin breakdown, contractures, pneumonia and prevent the development of deep 
vein thrombosis (DVT). Other early interventions could include range of motion 
exercises and regular changes in the patients bed position if they are unable to do so 
themselves. Patient fatigue could be overcome by reducing treatment times but 
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increasing the number of treatment sessions per day. Duncan et al. (2005) also 
suggests that treatment sessions be task-orientated i.e. familiar to the patient or 
adapting the tasks to suit their cognitive needs in order to gain more function. 
Progressive aerobic exercise can also assist with patient lethargy and progressive 
resistance exercises for muscle strengthening can be included in daily treatment 
sessions, in order to address the resultant changes in muscle fibres and atrophy 
induced by non-use (Duncan et al. 2005). 
 
Otherconventional therapies are used in stroke rehabilitation:Bobath, 
Neurodevelopmental therapy and Proprioceptive neuromuscular facilitation (Chauhan 
and Kumar, 2012). However, there is a need to involve motor control and motor learning 
by providing patient feedback. External rhythmic information provided by cue may 
reduce attentional load as it informs the motor system about temporal sequencing of a 
task, rather than needing to internally plan and prepare for the task (Chauhan and 
Kumar, 2012).  
 
Hartigan (2012) views goal setting as being fundamental to the rehabilitation process. 
The challenge lies in developing patient-centred intensive rehabilitation programmes as 
well as with self-directed exercise and activity. It is important to note at this point that 
the main member of the rehabilitation team is in fact the patient and the process of goal-
setting can enhance patient autonomy as they along with the therapists come to an 
agreement and understanding as to what their goals should be (Hartigan, 2012). The 
previous biomedical model used in rehabilitation falls short in this new concept as it 
does not view health as the individual’s ability to interact with their environments and 
participate in desired activities, hence the need for a team approach in goal-setting 
(Hartigan, 2012). This is supported by a study done by Lund et al. (2011) in which 
stroke survivors often reported unmet needs relating to their own well-being, 
experiences of anxiety, depression, lack of meaningful activities and restrictions in 
social participation within their daily lives up to five years post-stroke. 
 
Goal-setting is the process of dialogue and negotiation during which the patient and the 
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therapist determine the key rehabilitation goals found to be appropriate for that patient. 
This ‘patient-centred’ goal-setting is considered as ‘best practice’ in the rehabilitation 
setting (Hartigan, 2012).  
 
It is well known that functional impairment upon admission to a rehabilitation unit can 
greatly influence a patient’s functional outcome (delPilar Torres-Arreola, 2009). 
However, ineffective rehabilitation outcomes occur when rehabilitation behaviours 
become unstructured, lack purpose and lack direction all of which can result when goals 
are not set in place. A strong, positive self-awareness will empower the patient to 
consciously and actively identify realistic goals (Hartigan, 2012). 
 
2.10 Summary of Literature Review 
The purpose of this study has been to determine whether an individual’s HIV status, after 
suffering a stroke, plays any role in their functional ability after a period of interdisciplinary 
rehabilitation intervention has been provided to the individual.The treatment of stroke 
requires specialised care and resources but unfortunately only 10 – 20% of the South 
African population has access to this. Despite the clinical picture of stroke one must not 
forget that there exists two distinct types of stroke, (1)ischaemic and (2)haemorrhagic. 
Research shows that ischaemic strokes occur more frequently in the general population 
but the same is also true for those individuals who are HIV positive and have suffered a 
stroke. The study done in Groote Schuur Hospital, Cape Town, South Africa ; identified 
42% of HIV positive study participants’ first ever stroke was in fact the clinical event which 
resulted in their initial diagnosis of HIV. Risk factors for stroke differed between HIV-
associated stroke and HIV negative stroke. HIV negative risk factors included 
hypertension, diabetes, hypercholesterolemia and smoking; whereas HIV-associated 
stroke risk factors was limited to mainly infections at 28%. Stroke in general will remain the 
second most common cause of mortality worldwide, according to the WHO 2020 
projections. Gender plays a role regarding age of onset of stroke with females usually 
experiencing their first stroke 4.3 years after the male population.  
 
32 
 
 
 
Stroke alone has a devastating impact on the individual both physically and 
psychologically. Deficits in the upper limb and lower limb function are the most debilitating 
and persistent impairments seen post-stroke. Major depression or dysthymic disorders 
occur along with deficits in high order cognitive skills. This study has opened itself to 
research on not one disease but two, and whether their co-existence complicates the 
functional recovery of an individual who has suffered a stroke. HIV is a retrovirus or ‘slow’ 
virus as time from initial infection to appearance of clinical symptoms can take years. It is 
usually central nervous system abnormalities that are considered as first signs of infection 
i.e. stroke. This virus has similar effects on the body physically and psychologically as an 
individual who has suffered a stroke but who is HIV negative. Antiretroviral’sused to treat 
HIV unfortunately has a worsening effect of the symptoms. Over the past 3 years the 
number of new infections globally have fallen by 13%. However, Sub-Saharan Africa 
remains the most severely affected region with approximately one in every 20 adults living 
with HIV and this accounts for 71% of all individuals living with HIV worldwide. 
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CHAPTER 3 
 
3. Methodology 
 
3.1 Introduction 
This chapter describes the type of study performed and the steps taken to follow it through. 
Analysis of data retrieved is also explained in this chapter. 
 
3.2 Study design 
This was a retrospective longitudinal study utilising the review of subject records. 
 
3.3 Setting 
The subjects for the study were drawn from Witrand rehabilitation unit in the North-West 
province of South Africa. The North-West Province is found central north of South Africa 
and is completely landlocked, making up 0.5% of the total land area of the country(Jacobs 
et al.,2009) The North-West is reported as being one of the poorer provinces in South 
Africa. In the 2001 census 20% of the population that was ≥ 20 years old had no formal 
schooling(Jacobs et al.,2009). It is estimated that 69% of all households in the province 
lived in formal dwellings; 22% in informal structures and 5% in traditional structures 
(Jacobs et al., 2009). 
Witrand hospital, based in Potchefstroom, consists of 12 wards. Three of which are 
specialised: Emergency Unit, Rehabilitation Unit and the Psychiatric unit. The other nine 
wards serve as housing for those individuals who are intellectually and physically 
disabledwhose families are unable to care for them. The psychiatric and rehabilitation units 
serve the whole of the North-West province, as they are the only specialised units of their 
kind in the province. However, a majority of admissions tend to come from within the Dr 
Kenneth Kaunda District.The rehabilitation unit requests permission from all patients 
admitted to test for HIV. If the individual is unable to provide reliable consent then the 
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family is asked. If permission is granted, the patient undergoes pre-test counselling 
followed by post-test counselling. Information regarding the rehabilitation unit was obtained 
during a personal conversation with Miss J van der Linde, case manager of the 
rehabilitation unit, March 2010.  
 
3.4 Sample Selection and Size 
All subjects’ files dating back to 21 April 2005, the opening of the unit, to December 
2010 were analysed. There were 570 admissions to the unit during this time period of 
which 141 were stroke survivors that met the study’s inclusion criteria. The researcher 
reviewed all files and identified those relating to patients with stroke. These were then 
audited. Participants for the study were selected using the following criteria: 
 
3.4.1.Inclusion criteria: 
 First incident stroke survivors who were admitted to the Witrand 
rehabilitation unit in the North-West province between 2005 and 2010. 
 Subjects of all ages with stroke admitted during the specified period. 
 Subjects who were admitted and had a confirmed diagnosis of stroke. 
 Subjects with stroke whose functional ability was well documented 
using the SADFM (β – measurement tool) from admission to discharge. 
 
3.4.2 Exclusion criteria 
 Stroke survivors in which HIV status was undetermined and functional 
recovery was not determined using the SADFM (β – measurement 
tool). 
 Subjects with second time stroke. 
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3.5 Procedure 
3.5.1Ethical considerations 
 Ethical clearance was granted by the Human Research Ethics Committee 
(Medical) for the University of the Witwatersrand. Clearance 
numberM110493(See Appendix A). 
 Participant confidentiality was ensured at all times during data collection by 
not writing patient names on the data collection forms and ensuring the 
coding sheet was destroyed at the end of the study. 
 File numbers were used on the coding sheets to maintain confidentiality 
 
3.5.2 Pilot Study 
A pilot study was done prior to the main study. The aim of the pilot study was to 
determine whether the self–designed questionnaire was effective in the collection of 
appropriate data required for the study. 
 
3.5.2.1 Objectives of the Pilot Study 
 To determine if the questionnaire captured sufficient demographic and clinical 
information of the study group as well as the change in their functional abilities to 
fulfil the main objectives of the study 
 To obtain a basic understanding of the stroke population demographics. 
 
3.5.2.2 Methodology of the Pilot Study 
The pilot study was done through review of participant records.Ten files of patients with 
stroke were randomly drawn from the many files of patients with stroke admitted to the unit 
between21 April 2005 (the opening of the unit)and December 2010.  
Subjects were included or excluded into the pilot study using the criteria set for the main 
study. The pilot study was done after obtaining permission from the hospital authorities. 
Data were captured using the data collection sheet and compiled into HIV positive and 
HIV negative profile groups. 
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3.5.2.3 Results of Pilot Study 
Of the 10 files selected, six fulfilled the inclusion criteria. Five of these files were of 
participants who were HIV negative and one was HIV positive. In order to develop an 
HIV negative group profile, the mean of the data collected was used. Below is a table 
reflecting the findings. 
 
Table 3.1:Results of the pilot study 
 
 
 
 
 
 
 
3.5.2.4 Discussion and conclusion of pilot study results 
From these results it was clear that despite gaining on average the same number of 
points, it took the HIV positive individual 31 days longer to achieve this. In general the 
rest of the data did not differ significantly. The questionnaire was successful in collecting 
all the relevant data needed to fulfil the main objectives of the study, and thus required 
no further editing. Though only one individual was HIV positive from the reviewed files, 
the researcher’s experience from working at the hospital showed that there would be 
enough individuals for the main study.   
 
3.5.3 Main Study 
Ethical clearance was sought from and granted by the University of the Witwatersrand 
Human Research Ethics Committee (Medical)to perform the study. Permission to use 
hospital patient records in the study was also requested for and granted (AppendixB). 
Data collection from the hospital archives was done using self-designed data collection 
HIV POSITIVE PROFILE (n = 1) HIV NEGATIVE PROFILE (n = 5) 
Age: 42 years Mean age: 51.2 years 
Weight on admission: 63.6kg Mean weight on admission: 64.62kg 
β – Score on admission: 26 / 126 Mean score on admission: 56.6 / 126 
β – Score on discharge: 54 / 126 Mean score on discharge: 85.2 / 126 
Points gained: 28 Mean points gained: 28.6 
Length of stay: 49 days Mean length of stay: 17.8 days 
Risk factors: None Risk factors: 5had hypertension  
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sheets(AppendixC). In order to ensure confidentiality of data, the data collection sheets 
were coded using a random coding system of one alphabet letter linked with a number 
i.e. A1; A2 etc.A research assistant aided in drawing the archived stroke files but did 
not capture any data from said files to further ensure confidentiality.Data were 
collected from all the files of individuals who had suffered a stroke between 2005 and 
2010.This time period was chosen because the rehabilitation unit was using the β 
assessment tool to keep record of patient progress at the time. Over this five year 
period, 173 individuals suffering from stroke were treated at the Witrand Rehabilitation 
Unit. However, 32 patient files did not meet the inclusion criteria thus leaving a study 
group of 141 patient files. Information was captured from these files and was then 
analysed. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1Study Group 
 
 
Total number of stroke survivors 2005 – 
2010 
 
173 
Number of strokes not meeting inclusion 
criteria 
 
32 
Study group (n) = 141 
HIV status 
undetermined 
 
1 
Stroke subtype not 
determined 
 
3 
Function not scored 
using Beta assessment 
 
8 
Multiple strokes 
 
 
18 
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3.6Instrumentation and Outcome Measures 
a) The South African Database for Functional Medicine (Beta assessment tool) 
 
The South African Database for Functional Medicine (Beta assessment tool) was used 
to determine patients’ functional ability (AppendixE). The β – score assessment tool is 
one of three platform level tools designed by the South African Database for Functional 
Medicine (SADFM).It allows the assessor to monitor a patient’s progress as it is 
reported on a weekly basis(www.sadfm.co.za, 2010). It also allows for developmental 
research into health care outcomes.It is based on the well-known American version, the 
Functional Independence Measure. This tool works within the World Health 
Organisation framework of the International Classification of Function, Disability and 
Health (www.sadfm.co.za, 2010). 
 
The β – score assessment tool can be used in sub-acute settings where one can 
compare the difference between admission and discharge scores of patients to 
determine improvement in functional abilities(www.sadfm.co.za, 2010). It is an evidence 
– based scoring system which can convert a patient’s functional abilities and behaviour 
into quantifiable data. Patients are scored by a multi-professional team, covering 18 
areas with points given between one and seven. Thirteen of the items are physical 
domains and five are cognition items. In order to score the patient, therapists require an 
hour of training and should pass a written exam in order to be qualified to use this 
measurement tool (www.sadfm.co.za, 2010). Functional ability is assessed on the basis 
of direct observation.  
The patient is scored on what they actually do on a daily basis and not on what they 
could do (www.sadfm.co.za, 2010). If the patient’s performance varies from day to day 
the therapist must score them on their lowest performance score. Areas assessed 
include: Eating; Grooming; Bathing; Dressing upper body; Dressing lower body; 
Toileting; Bladder management; Bowel management; Transfers: Bed, chair, wheelchair; 
Transfers: Toilet; Transfers: Tub, shower; Locomotion: Walking, wheelchair; 
Locomotion: Stairs; Comprehension; Expression; Social interaction; Problem Solving 
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and Memory (www.sadfm.co.za, 2010).As mentioned before the patient is scored using 
a point system from 1 to 7. Below is a table explaining the definition for each point: 
 
Table 3.2: The Beta Scoring System 
Score Definition 
1 The subject does not assist at all. They are completely dependent on 1 or 2 therapists 
to complete the task. 
2 The subject tries to assist, but provides less than half of the effort (25 – 49%). 1 
therapist is required to complete the task. 
3 The subject performs 50 – 75% of the task but still requires the help from 1 therapist. 
4 The subject requires incidental hands on help only. They perform > 75% of the task. 
5 The subject requires supervision, cuing and/or setting-up to complete the task. 
6 The subject requires extra time or used an assistive device. 
7 The subject is fully independent. 
(www.sadfm.co.za, 2010) 
The higher the β – score, the greater the functional ability. A normal score for a fully 
functional individual is 126/126(www.sadfm.co.za, 2010). The β – score tool was 
chosen due to its convenience as well as high reliability as evidenced by it’sCronbach’s 
Alpha coefficient which showed that it had a “high to very high” internal consistency 
(www.sadfm.co.za, 2010). On admission the internal consistency was calculated as 
high as 0.96 and 0.98 on discharge scores (www.sadfm.co.za, 2010). Results from a 
Rasch analysis for construct validity are not yet available. 
b) Demographic Questionnaire 
The patient’s demographic information and clinical characteristics was captured using a 
self-designed questionnaire (AppendixC). The information captured included age, 
gender, weight, race, hospital length of stay, number of strokes patient had, stroke 
subtype, co-morbidities present, date of admission, date of discharge, date of stroke, 
HIV status and whether they were receiving ARV’s and their latest CD4 count.  
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3.7 Data Analysis 
For data analyses, the various variables were categorised as follows: 
 
Table 3.7.1 Data variables 
Independent Variables 
Dependent Variable 
Categorical Variables Continuous Variables 
- Gender 
- HIV status 
- ARV’s 
- Race 
- Hypertension 
- Diabetes Mellitis 
- Cholesterol 
- Stroke sub-type 
- Type of rehabilitation 
received 
- Age 
- CD4 count 
- Hospital length of stay 
- Weight 
- ARV treatment regime 
duration 
- Stroke duration 
 
- Functional status 
 
 
For data analysis the p-value was set at p ≤ 0.05 with the confidence interval set at 
95%. The data collected from the study group (n = 141) was first analysed using 
descriptive statistical tests to describe the group demographics and clinical 
characteristics. Categorical data was summarised as numbers and percentages and 
continuous data was summarised as means and standard deviations.  A two sample t-
test was used to compare mean admission and discharge functional scores between 
the HIV negative and HIV positive patients and to compare the functional change in 
ability of patients who were HIV positive and those who were HIV negative on 
discharge. 
 
 
 
 
CHAPTER 4 
 
4. RESULTS 
 
4.1 Introduction 
The objectives of this study were:1) To describe the group demographics and clinical 
characteristics of patients admitted to the Witrand rehabilitation unit, 2) To establish and compare 
the functional abilities of patients who are HIV positive with those who are HIV negative on 
admission to the Witrand rehabilitation unit, 3) To establish and compare the functional abilities of 
patients who are HIV positive with those who are HIV negative on discharge from the Witrand 
rehabilitation unit and 4) To compare the functional change in ability of patients who are HIV 
positive and those who are HIV negative on discharge from the Witrand rehabilitation unit. 
Study participants’ demographics and clinical characteristics are described using the data collected 
using the demographic questionnaire. The β-scores results arepresented to indicate functional 
ability of the stroke survivors which allowed comparisons between the admission and discharge 
scores of the two groups, i.e. patients with stroke who were HIV positive and negative. 
 
4.2  Demographics and clinical characteristics of the study group 
Figure 4.1 below provides a description of the study group’s gender, HIV status and CD4 count. 
 
 
 
 
 
 
 
 
 
 
 
 
 
42 
 
 
 
 
 
 
 
 
Figure 4.1:Study group’s gender, HIV status and CD4 count 
 
 
From the year 2005 to 2010, 173 stroke survivors were admitted to the Witrand rehabilitation unit. 
From this total, 32 patient files were excluded for not meeting the inclusion criteria and hence data 
from 141 files were used for the study (n).  There were 75 (53.2%) male and 66 (46.8%) female 
stroke survivors. The mean age for the patients with stroke was 54.4 ± 3years for male and   
52.4±3.3 years for female stroke survivors.   About 57% of those patients with stroke who were HIV 
positive had a CD4 count below 350cells/mm3. 
 
The demographic details and clinical characteristics of the categorical variables of the study group 
are shown in Table 4.1 below. 
 
 
 
CD4 count < 350 cells/mm³ = 12 (57.1%) CD4 count > 350 cells/mm³ = 9 (42.9%) 
Total number on ARV’s = 11 (52.4%) 
Total number of stroke survivors 2005 – 2010 
173 
Number of strokes not meeting inclusion 
criteria: 
32 
Study group (n) = 141 
 
75 Males (53.2%) 
Mean age = 54.4 ± 3 years  
66 Females (46.8%) 
Mean age = 52.4 ± 3.3 years  
Total number of HIV positive individuals = 21  
(14.9%) 
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Table 4.1: Study group demographics and clinical characteristics: Categorical variables 
 HIV Positive 
n = 21 (14.9%) 
n(%) 
HIV Negative 
n = 120 (85.1%) 
n(%) 
Total 
n = 141 (100%) 
n(%) 
Gender 
Male 
 
Female 
 
8 (38.1) 
13 (61.9) 
 
67 (55.8)  
53 (44.2) 
 
75 (53.2) 
66 (46.8) 
Race 
African 
 
Caucasian 
 
Coloured 
 
Indian 
 
 
21 (100.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
 
80 (66.7) 
33 (27.5) 
6 (5.0) 
1 (0.9) 
 
101(71.6) 
33 (23.4) 
6 (4.3) 
1 (0.7) 
Subtype 
Ischaemic 
 
Haemorrhagic 
 
20 (95.2) 
1 (4.8) 
 
85 (70.8) 
35 (29.2) 
 
105 (74.5) 
36 (25.5) 
Hypertension 8 (34.8) 37 (31.4) 45 (31.9)  
Diabetes 2 (9.5) 7 (5.8) 9 (6.4) 
Cholesterol 2 (9.5) 6 (5.0) 8 (5.7) 
Treatment received: 
Medical Officer, 
Physiotherapist, 
Occupational 
therapist, Clinical 
Psychologist, 
Dietician and Nursing 
21 (100.0) 
 
120 (100.0) 
 
141 (100.0) 
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All the patients who were HIV positive were of African descent and they also had the greatest 
number of admissions (71.6%) to the rehabilitation unit over the period 2005 – 2010.  Ischaemic 
strokes were more prevalent than haemorrhagic strokes (74.5% and 25.5% respectively) and 
hypertension (31.9%) was the most common stroke risk factor. 
 
The demographic details and clinical characteristics of the continuous variables of the study group 
are shown in Table 4.2 below. 
 
Table 4.2:Study group demographics and clinical characteristics: Continuous variables 
 HIV Positive 
n = 21(14.9%) 
HIV Negative 
n = 120 (85.1%) 
Total 
n = 141 (100%) 
Mean (SD) Mean (SD) Mean (SD) 
Age (Years) 39.6 (±10.8) 54.9 (±13.6) 52.7 (±14.3) 
Length of Stay 
(Days) 
30.5 (±8.8) 38 (±15.6) 36.9 (±15.1) 
Weight (Kg) 58.4(±16.3) 67.1 (±16.8) 65.8 (±17.0) 
Stroke duration 
prior to admission 
to Witrand hospital 
(days) 
26.2 (±14.4) 25.7 (±24.0)  25.8 (±22.7) 
 
 
There was a discrepancy in age of stroke onset between those individuals with HIV and those 
without HIV. The age of stroke onset in the HIV positive group is on average ± 15 years earlier than 
those individuals who are HIV negative. The HIV negative group appears to require approximately 
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a week longer of rehabilitation intervention. Both groups began their rehabilitation at approximately 
the same time period after stroke onset. Information regarding the ARV treatment regimens 
patients were on during their stay in hospital was insufficient and thus no meaningful data could be 
obtained from this study sample. 
 
4.3 Functional abilities of patients on admission and at discharge  
The patient functional abilities were measured using beta scores. Results of the functional abilities 
of the study group on admission, on at discharge and the change in functional ability 
fromadmission to discharge are shown in Table 4.3 below.   
 
Table 4.3:Patient functional ability represented by mean Beta scores 
 HIV positive 
(n =21) 
HIV negative 
(n = 120) 
 
 Mean Beta score/126(SD) Mean Beta score/126(SD) p-value 
Beta scores on 
admission  
56 (±21) 60 (±25) 
0.53 
Beta scores at 
discharge 
96 (±28) 97 (±23) 
0.60 
Mean Beta 
scores change 
from admission 
to discharge 
40 (±19) 38 (±20) 
 
0.88 
SD = Standard deviation 
The mean beta scores of the two groups on admission and discharge were not statistically 
significant. The mean change differences in beta scores between the two groups were also not 
statistically significant. 
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CHAPTER 5 
 
5. Discussion 
5.1 Introduction 
This chapter serves to further study and discuss the results obtained in this study. Comparisons 
of results will also be made and discussed based on literature reviewed in Chapter 2. Results 
obtained will be discussed under the following subheadings: Study group’s gender, age, HIV 
status, CD4 count, length of stay (L.O.S) and stroke duration; Study group clinical 
characteristics; Functional abilities of study participants and Limitations of the study. 
 
5.2 Study group’s gender, age, HIV status, CD4 count, L.O.S and stroke duration 
There were more male stroke patients (53%) in this study group which resulted in a male to 
female ratio of 1.1:1. This finding is almost similar to that by Mochan et al’s(2003) study in 
which stroke was found in participants with a male to female ratio of 1.5:1. However, results of 
this study showed that within the HIV positive group more females appeared to be affected by 
stroke than males (13 females to 8 males) with a male to female ratio of 1:1.6. Stroke affects 
males at an earlier age than females within the general population, with females having stroke 
approximately 4.3 years later than men(Appelros, 2009). In this study, however, there was no 
difference in age of stroke onset, with male’s average age of onset being 54.4 years and 
females 52.4 years. The greater number of females with HIV could stem from the fact that there 
are more females with HIV infection than males in sub-Saharan Africa (Glynn et al., 2001). In 
several areas in Sub-Saharan Africa it was noted that there existed a greater prevalence of HIV 
in young women, possibly as a result of greater exposer to infected partners, or due to their 
higher risk of acquiring HIV from an infected partner (Glynn et al, 2001). 
 
Of those individuals suffering from HIV, 12 individuals (57%) had a CD4 count of <350 
cells/mm³. In South Africa, antiretrovirals are administered once an individual’s CD4 count is ≤ 
350 cells/mm³(South African Antiretroviral Treatment Guidelines, 2013).Thus it is important to 
note that 11 individuals of the study group were receiving ARVs. It can therefore extrapolated 
that possibly the public health sector is implementing this treatment protocol effectively.  The 
introduction of ARV’s into one’s treatment regimen has the potential to improve one’s CD4 
count which could further prevent the development or onset of other diseases, lessening the 
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health burden to a degree(Lemogoum et al., 2005).  
 
There is a considerable difference in age of stroke onset when comparing the individuals who 
were HIV positive with those who were HIV negative. The mean age of stroke onset for an 
individual with HIV was 39.6(±10.8) years, whereas the mean age of stroke onset for 
individuals that did not have HIV was 54.9(±13.6)years.  In a study by Lemogoum et al. (2005) 
it was noted that stroke generally affected a younger population in developing countries 
compared to developed countries. Tobias et al. (2007) found that the average male onset of 
stroke was 68.9 years and 73.3 years for females, with males having ± 20% higher prevalence 
rate than that of females, supporting the older onset of stroke in the Western world (Tobias et 
al., 2007). It should be noted that the average age of stroke onset is 54.9 years in the HIV 
negative group, approximately 14 and 18 years earlier than the average age of stroke onset in 
males and females in the Western world respectively. Stroke can no longer be considered an 
‘old-age’ disease in developing countries.  
 
5.3 Study group clinical characteristics 
The two subtypes of stroke appear in both clinical groups,i.e. the HIV positive and HIV negative 
individuals. In keeping with the literature, ischaemic strokes were more common than 
haemorrhagic strokes, with a ratio of 3:1(Lee et al., 2011; Turanjanin et al., 2011; Spengos and 
Vemmos, 2010; Appelros et al., 2009; Cabral et al., 2009; Benjamin et al., 2012). The risk for an 
ischaemic stroke is a further 3-4 fold greater in individuals with hypertension which is important 
when one considers the importance of hypertension as a stroke risk factor (Turanjanin et al., 
2011).  Lemogoum et al. (2005) found that despite cerebral haemorrhage being a leading cause 
of stroke fatality in Sub-Saharan Africa, cerebral infarction occurred more often.  Regarding risk 
factors for stroke, hypertension far exceeded the others, affecting 34.8% in the HIV positive 
group and 31.4% in HIV negative group. Rigby et al. (2009) found hypertension to affect 80% of 
the stroke survivors in their study. Despite the vast difference in numbers within each of the 
study groups, this study confirmed this trend. Hypertension is the most consistent and powerful 
predictor of stroke and is involved in approximately 70% of all strokesLemogoum et al. (2005). 
Treatment of hypertension has the potential to reduce stroke risk by 35% - 40%, yet surveys still 
indicate poor control of hypertension in Africa (Lemogoum et al., 2005). Therefore, public 
education and awareness on stroke risk factors would greatly assist in lessening the social and 
economic burden of stroke.  
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Diabetes affected 9.5% of individuals with HIV as opposed to 5.8% of individuals without HIV. 
This validates Young et al’s (2009) findings in which it was stated that individuals with HIV were 
at a higher risk of developing diabetes. The rapid leap towards urbanisation in Sub-Saharan 
Africa has been argued to lead to a rise in the prevalence of diabetes and other cardiovascular 
diseases (Mbanya et al., 2010).  
 
This study found that HIV positive individuals stayed at the hospital on average 30.5(±8.8) days, 
whereas HIV negative individuals stayed for an average 38(±15.6) days. This discrepancy could 
be a result of the notably younger HIV positive group in this study.  It could be argued that the 
advantage of age on recovery in this groupcould result in gaining, on average, a similar number 
of points on the beta scale with those individuals without HIV. It must be mentioned that this 
gain in points also occurred over a shorter time period. Thus one could reason that age was the 
determining factor in the more efficient positive outcome. However, when looking at the bigger 
picture, a younger population of individuals are being affected by stroke as a result of their HIV 
status. This could result in the growth of a younger ‘disabled’ population possibly resulting in an 
increase in the applications for disability grants. If younger individuals are not working one could 
assume a negative effect on our work force and labour if return to work is not possible. 
 
5.4Functional abilities of study group 
 
a) On admission 
Functional ability was determined by the individual’s beta score out of 126. Both HIV positive 
and HIV negative individuals were admitted at approximately the same amount of time post-
stroke, 26.2 and 25.7 days respectively. This could have contributed to some extent to the little 
differences noted in functional ability between the two groups. 
 
The mean beta scores for individuals with HIV was 56 points and for individuals without HIV 
was 60 at admission. The recovery of motor function has been documented to occur most 
effectively during the first month post-stroke, allowing for the improvement of motor deficits 
(Schaechter, 2004; Rossini et al., 2003; Hendricks et al., 2002).In both groups the rehabilitation 
process was allowed to begin at approximately the same period of time post- incident. 
Functional recovery is influenced by an array of biological and environmental factors (Hendricks 
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et al., 2002). Allowing for rehabilitation to occur at a similar time frame post-incident eliminates 
any bias towards a specific group. 
 
Age at stroke onset appeared to be the greatest variance between the HIV negative group and 
the HIV positive group. This is more than likely as a result of the age of the group most at risk of 
developing HIV (Benjamin et al., 2012). Prior to their commencement of rehabilitation it should 
be taken into account that neurological recovery requires a degree of brain reorganization and 
that with age comes a certain degree of neuronal loss (Teasell et al., 2005). Neuroplasticity is 
the ability of the central nervous system to respond to internal and external stimuli by 
reorganizing its structure, function and connections (Cramer et al., 2011). Normal ageing is 
associated with a decline in and reduced plasticity (Cramer et al., 2011). These negative 
changes can be experienced as reductions in processing speed, working memory and 
peripheral nervous system functions; all of which can be associated with poorer rehabilitation 
outcomes (Cramer et al., 2011). Consequently one should expect adissimilarity in the two 
group’s performance and ability to rehabilitate.   
 
Ischaemic stroke subtype proved more common in the study group as a whole, as well as within 
each of the clinical groups. This is supported by literature from Lee et al., 2011;Turanjanin et al., 
2011; Spengos and Vemmos, 2010; Appelros et al., 2009; Cabral et al., 2009. The global use of 
cART in HIV positive patients increases life expectancy and thus their risk for an ischaemic stroke 
due to its high correlation with age (Obviagele and Nath, 2011). In this study 11 of the 12 patients 
whose CD4 count was ≤350cells/mm³ were receiving ARVs. 
 
b) Rehabilitation and function at discharge from hospital 
After receiving rehabilitation from a multidisciplinary team, the HIV positive group was 
discharged with a mean functional score of 96 points and the HIV negative group on 97 points. 
Studies evaluating the efficacy of post-stroke rehabilitation across different settings will find 
inconsistencies in the day-to-day treatment of patients (Schaechter, 2004). In this study that 
was minimised by exposing all stroke survivors to the same time period and level of treatment 
intensity on a daily basis. It is also important to note that some functional recovery does occur 
spontaneously as a result of the resolution of oedema in the brain, as well as possible recovery 
of tissue function in tissues that were ischaemic but not destroyed (Hallet, 2001).Despite the 
negative effects that HIV and ARV’s have on the body and its physical performance, the use of 
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cART to achieve immune restoration is effective (Tan et al., 2012). Therefore the fact that a 
younger population of individuals suffered HIV but were being treated with ARV’s allowed 
relatively stronger individuals to approach the rehabilitation process with more energy and 
better muscle strength (Greig et al., 1994). 
 
During their stay the individuals with HIV improved with an average of 40 points and the 
individuals without HIV by 38 points. This change in score appears similar for both groups but 
the individuals with HIV took on average 8 days longer to achieve this increase in points. Again 
age could be considered as the deciding factor when trying to understand this difference in 
length of stay. Neural plasticity is crucial for functional recovery and this occurs more effectively 
and efficiently in younger individuals (Voytek et al., 2010). 
 
When performing the various t-tests there were, in fact, no significant differences between the 
two different clinical groups.  
 
5.5. Limitations 
The small group of HIV positive individuals in this study did not provide sufficient power against 
the HIV negative individuals when performing the statistical analysis, yielding results that were 
not statistically significant. The vast difference in numbers of the two groups had an  influence 
on the generalizability of the results of this study. Challenges to a study of this nature include 
therapist consistency over the five years. Eventhough therapists are trained in scoring the 
patients on the outcome measure and write an examination to be given permission to use the 
tool, therapist observations of the patients whilst scoring remains subjective. Thus certain 
patients may be scored more conservatively than others. It should be noted that blinding of the 
principle investigator was not necessary as data was collected after the five year period (2005-
2010).  The study wasalso limited to individuals admitted to only one hospital and thus again a 
similar study using a larger study group would provide more definitive results.It should also be 
noted that demographical information captured was specific to age and gender; a more 
extensive demographical profile should be created in future studies. 
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CHAPTER 6 
 
6. Conclusion and recommendations 
6.1Conclusion 
Despite the statistically insignificant findings when comparing the HIV positive and HIV negative 
group functional outcomes, when taking a closer look at the study group’s demographics and 
clinical characteristics, this study yielded interesting results.  
 
There were more male stroke patients (53%) in this study group which resulted in a male to 
female ratio of 1.1:1. However, results of this study showed that within the HIV positive group 
more females appeared to be affected by stroke than males (13 females to 8 males) with a male 
to female ratio of 1:1.6. There is a considerable difference in age of stroke onset when 
comparing the individuals who were HIV positive with those who were HIV negative. The mean 
age of stroke onset for anindividual with HIV was 39.6 years, whereas the mean age of stroke 
onset for individuals that did not have HIV was 54.9 years. The African race was also more 
severely affected by stroke than any other.  
 
In both groups the rehabilitation process was allowed to begin at approximately the same 
amount of time post- incident.  As a result, both groups did not differ significantly on admission in 
terms of functional ability. The mean beta scores for individuals with HIV was 56 points and for 
individuals without HIV was 60. 
 
After receiving rehabilitation from a multidisciplinary team, the HIV positive group was 
discharged with a mean functional score of 96 points and the HIV negative group on 97 points. 
As mentioned before, group age is the key to a positive outcome. 
 
Thus during their stay the individuals with HIV improved with an average of 40 points and the 
individuals without HIV by 38 points. However this improvement in scores was achieved over 
different time periods. The younger HIV positive group achieved their increase in score over a 
period that was 7.5 days shorter than individuals in the HIV negative group. 
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6.2 Recommendations 
This small group of HIV positive individuals in this study did not provide sufficient power against 
the HIV negative individuals when performing the statistical analysis, yielding results that were 
not statistically significant. The same study should be performed using a larger sample size and 
particularly one in which the individuals in the two groups are closer in sample size; thus 
providing the statistical power to provide a more definitive study result.  
 
We can infer from these findings that patients who sustain stroke, are HIV positive, are 
receiving ARVs and rehabilitation treatment, can recover to the same level as those who are 
HIV negative within a similar amount of stay in a rehabilitation hospital. We can therefore argue 
that patients with stroke who are HIV positive should receive ‘normal’ rehabilitation like any 
other stroke patient. 
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Appendix C:  Demographic Questionnaire 
 
CODE: 
 
 
 
Date:          Collected by: 
 
This collection sheet has been coded at random and in no way provides information that can be used to 
trace the data back to a specific file 
 
HIV Status 
 
Positive 
 
Negative 
CD4 count 
 
ARV’s 
 
Date ARV Rx 
started 
 
AdmBeta-
score 
 
D/C  
Beta-score 
 
Gender 
 
Female 
 
Male 
Race African Caucasian Coloured Indian 
Age 
 
Weight 
 
D.O.A 
 
Date of D/C 
 
L.O.S 
 
No. stroke 
 
Subtype 
 
Haemorrhage 
 
Ischaemic 
D. O. I 
(Date of Incident) 
 
Risks HPT DM Cholesterol Post-natal 
Type of Rehabilitation (Tick appropriate blocks) 
 Physiotherapy  Occupational 
therapy 
 Speech 
Therapy 
 Psychology  Dietetics  Medical 
Officer 
(daily) 
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Appendix D: Coding Sheet 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date:          Collected by: 
 
 
 
File Number Code 
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APPENDIX E: Beta Scoring Sheet 
 
 
